The Latest Breaking News from Vertex

The Dow Jones Industrial Average rallied 130 points Wednesday ahead of the Federal Reserve's interest-rate decision.

The Dow Jones Industrial Average fell Tuesday, as Walmart plunged on a profit warning. Alphabet and Microsoft earnings are due late.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Ten years ago this week, Jennifer Doudna and her colleagues published the results of a test-tube experiment on bacterial genes. When the study came out in the journal Science on June 28, 2012, it did not make headline news. In fact, over the next few weeks, it did not make…

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

As tech titans like Apple and Nvidia get shunned again, the best mutual funds focus on Big Pharma and biotech stocks.

The biotech industry is trying to catch the ESG investing bug. But that doesn't mean investors are giving it credit, executives say.

The FDA cleared Vertex to restart testing a diabetes treatment, and VRTX stock jumped to a fresh high Wednesday.

As the market regroups, 25 names — including Vertex, WWE, Li Auto and KO stock — make the IBD Breakout Stocks Index.

As the Biotech industry’s role in finding cures for chronic diseases and critical conditions is expected to keep attracting investors’ attention, it could be wise to scoop up shares of the fundamentally-strong biotech companies Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR), Amgen (AMGN), and Sino Biopharmaceutical (SBHMY) because of their solid…

The stock market rally searched for direction Wednesday. Jobless claims and inflation data are on tap.